What's Happening?
Tandem Diabetes Care International is actively recruiting for a Director of Medical Affairs for the EMEA (Europe, Middle East, and Africa) region. This role is pivotal in supporting the company's expansion and product launches, particularly for its diabetes
technology, including the Tandem Mobi system and t:slim X2 insulin pump with Control-IQ+ technology. The Director will be responsible for developing and executing regional Medical Affairs strategies, leading evidence generation initiatives, and building relationships with healthcare professionals and key opinion leaders across EMEA. The position requires extensive travel throughout Europe and a strong understanding of European medical device regulations, such as EU MDR and CE Mark requirements. The ideal candidate will have significant Medical Affairs leadership experience within the medical device, MedTech, or pharmaceutical industry.
Why It's Important?
This recruitment signifies Tandem Diabetes Care International's strategic focus on strengthening its presence and market penetration in the EMEA region. The Director of Medical Affairs will play a crucial role in ensuring that Tandem's innovative diabetes technologies gain regulatory approval, secure reimbursement, and achieve market access in diverse European healthcare systems. This expansion could lead to increased availability of advanced insulin delivery systems for individuals with diabetes in these regions, potentially improving patient outcomes and quality of life. For Tandem, successful market expansion in EMEA would translate into significant business growth and a stronger global competitive position in the diabetes technology sector. The emphasis on evidence generation and engagement with healthcare professionals highlights the importance of clinical validation and medical community acceptance for new medical devices.
What's Next?
The company will proceed with the hiring process to fill this critical leadership position. Once appointed, the new Director of Medical Affairs will be tasked with implementing the regional strategy, which includes fostering collaborations with clinical affairs, regulatory, market access, marketing, and commercial teams. Their efforts will directly influence the success of product launches and market expansion initiatives across EMEA. This will involve delivering scientific presentations, providing medical expertise to field teams, and establishing regional advisory boards. The role's focus on evidence generation will also contribute to future research and development, ensuring that Tandem's products continue to meet evolving market needs and regulatory standards.
Beyond the Headlines
The strategic importance of this role extends beyond immediate market expansion. By investing in a strong Medical Affairs presence, Tandem Diabetes Care International is positioning itself to navigate the complex regulatory and reimbursement landscapes of the EMEA region more effectively. This proactive approach can help overcome barriers to adoption for new medical technologies, ensuring that innovations reach patients who need them. Furthermore, the emphasis on building relationships with key opinion leaders and scientific organizations underscores a commitment to medical education and the integration of advanced diabetes management solutions into clinical practice. This could set a precedent for how other medical device companies approach international market entry and engagement.













